2020 annual financial data

Entrada Therapeutics 2020 Net margin

Entrada Therapeutics 2020 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -26,667,000 USD and net income was -26,523,000 USD.
Operating cash flow was -25,570,000 USD.

Get free Entrada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-26,667,000 USD
Net income
-26,523,000 USD
Operating cash flow
-25,570,000 USD